- Home
- IMVT vs BSM Comparison
IMVT vs BSM Comparison
Compare IMVT & BSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- BSM
- Stock Information
- Founded
- IMVT 2018
- BSM 1876
- Country
- IMVT United States
- BSM United States
- Employees
- IMVT N/A
- BSM N/A
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- BSM Oil & Gas Production
- Sector
- IMVT Health Care
- BSM Energy
- Exchange
- IMVT Nasdaq
- BSM Nasdaq
- Market Cap
- IMVT 2.7B
- BSM 2.5B
- IPO Year
- IMVT N/A
- BSM 2015
- Fundamental
- Price
- IMVT $16.00
- BSM $13.49
- Analyst Decision
- IMVT Buy
- BSM Hold
- Analyst Count
- IMVT 10
- BSM 1
- Target Price
- IMVT $33.38
- BSM $13.00
- AVG Volume (30 Days)
- IMVT 1.7M
- BSM 436.6K
- Earning Date
- IMVT 11-06-2025
- BSM 11-03-2025
- Dividend Yield
- IMVT N/A
- BSM 8.88%
- EPS Growth
- IMVT N/A
- BSM N/A
- EPS
- IMVT N/A
- BSM 1.16
- Revenue
- IMVT N/A
- BSM $413,675,000.00
- Revenue This Year
- IMVT N/A
- BSM $7.94
- Revenue Next Year
- IMVT N/A
- BSM $6.80
- P/E Ratio
- IMVT N/A
- BSM $11.61
- Revenue Growth
- IMVT N/A
- BSM N/A
- 52 Week Low
- IMVT $12.72
- BSM $11.78
- 52 Week High
- IMVT $32.10
- BSM $15.66
- Technical
- Relative Strength Index (RSI)
- IMVT 50.79
- BSM 64.51
- Support Level
- IMVT $15.81
- BSM $12.96
- Resistance Level
- IMVT $17.15
- BSM $13.53
- Average True Range (ATR)
- IMVT 0.73
- BSM 0.21
- MACD
- IMVT 0.10
- BSM 0.04
- Stochastic Oscillator
- IMVT 57.98
- BSM 91.61
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About BSM Black Stone Minerals L.P. Common units representing limited partner interests
Black Stone Minerals LP is an oil and natural gas mineral company. It owns oil and natural gas mineral interests, which makes up the majority of its asset base. Its business is actively managing an existing portfolio of mineral and royalty assets to maximize its value and expanding asset base through acquisitions of additional mineral and royalty interests.